Niğde Ömer Halisdemir University Training and Research Hospital
Niğde, Niğde Province, 51200, Turkey (Türkiye)
NCT Number: NCT07521306
This retrospective study aimes to analyze the association of a number of routinely performed biomarkers with mortality in patients admitted to ICU with suspected sepsis.
The study includes patients >18 years of age, who had been admitted to the ICU with suspected sepsis. At ICU admission, baseline levels of PCT, CRP, albumin and lactate as well as WBC, neutrophil and lymphocyte counts will recorded.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Niğde, Niğde Province, 51200, Turkey (Türkiye)
This study aimes to investigate the association of a number of biomarkers with 28-day mortality of patients admitted to the ICU with suspected sepsis, which included C-reactive protein (CRP), procalcitonin (PCT), WBC count, neutrophil count, lymphocyte count, albumin and lactate.
Data will obtained from hospital electronic medical records. Data includes age, sex, duration of ICU stay, origin of infection (urinary, abdominal, pulmonary, soft tissue, central nervous system, catheter-related, mixed, others) and comorbidities (hypertension, diabetes mellitus, chronic obstructive pulmonary disease, chronic renal failure, heart failure, coronary artery disease, malignancies, others). Whether patients were admitted to the ICU following a scheduled surgery or emergency surgery will also recorded.
At admission, baseline levels of PCT, CRP, albumin and lactate as well as WBC, neutrophil and lymphocyte counts will recorded.
The primary outcome is 28-day mortality. For patients with multiple episodes requiring ICU admission, only the most recent episode will taken into consideration.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 28 days
mortality within 28 days after intensive care admission
Antalya Training and Research Hospital
Other Gov
The Use of Biomarkers for Predicting Mortality in Patients With Suspected Sepsis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04724044
Biomarkers, Community-Acquired Infections
Athens, Greece
View Trial DetailsNCT03345992
Bacterial Infections, Bacterial Infections and Mycoses
Brussels, Belgium
View Trial DetailsNCT03837730
Biomarkers, Infection
Besançon, France
View Trial DetailsNCT03005145
Antimicrobial, Bacteremia
New York, United States
View Trial Details